Tertiary cytoreduction for recurrence of ovarian CANCER patients after intraperitoneal chemotherapy

IntroductionThis study evaluated the feasibility, complications, and outcomes of a tertiary cytoreduction after second-line treatment with IP (intraperitoneal) versus IV (intravenous) chemotherapy in recurrent ovarian cancer (ROC) patients.MethodsWe retrospectively collected data of patients treated...

Descrición completa

Detalles Bibliográficos

Principais autores:	Giusi Santangelo, Enrico Ciminello, Tullio Golia d’Augè, Violante Di Donato, Federica Tomao, Innocenza Palaia, Margherita Fischetti, Giorgio Bogani, Ludovico Muzii, Pierluigi Benedetti Panici, Giorgia Perniola
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2025-11-01
Series:	Frontiers in Medicine
Assuntos:	recurrent ovarian cancer intraperitoneal chemotherapy intravenous chemotherapy tertiary cytoreduction adhesion score
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1691155/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!